Current Projects
-
OUTcomes POST COVID - Australian Platform Trial (OUTPOST-APT)
The overall objective was to robustly determine the prevalence and disease burden of Long COVID at a time when a high proportion of the population was vaccinated, had prior infection, had access to antiviral medication, and with current milder variants in circulation.
-
Evidence-Based Antimicrobial Stewardship: Sustainable Implementation in Primary Care - The EASSI-PC Trial
Over 10 million Australians receive antibiotics each year, often for self-limiting infections, which contributes to the avoidable and growing threat of antimicrobial resistance. This threatens the availability of affordable and reliable treatments for everyday infections and brings us closer to a post-antibiotic era.